Hyphen BioMed
FIX Deficient Plasma (1 x 1 mL)
In US: For Research Use Only. Not for Use in Diagnostic Procedures. Deficient plasma for the assay of Factor IX. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FIX, which is brought by the diluted tested plasma, and clotting is triggered with cephalin, activator and calcium (APTT).
FIX Deficient Plasma (1 x 1 mL)
In Canada: Health Canada licensed. Deficient plasma for the assay of Factor IX. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FIX, which is brought by the diluted tested plasma, and clotting is triggered with cephalin, activator and calcium (APTT).
FVIII:C Deficient Plasma (6 x 1 mL)
In US: For Research Use Only. Not for Use in Diagnostic Procedures. Deficient plasma for the assay of Factor VIII:C. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FVIII:C, which is brought by the diluted tested plasma, and clotting is triggered with cephalin, activator and calcium (APTT). FVIII:C is the limiting factor and clotting time is inversely proportional to the concentration of FVIII:C.
FVIII:C Deficient Plasma (6 x 1 mL)
For In Vitro Diagnostic Use. In EU: This Product is CE Marked. Health Canada Licensed. Deficient plasma for the assay of Factor VIII:C. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FVIII:C, which is brought by the diluted tested plasma, and clotting is triggered with cephalin, activator and calcium (APTT). FVIII:C is the limiting factor and clotting time is inversely proportional to the concentration of FVIII:C.
FVIII:C Deficient Plasma (6 x 1 mL)
For In Vitro Diagnostic Use. In EU: This Product is CE Marked. Health Canada Licensed. Deficient plasma for the assay of Factor VIII:C. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FVIII:C, which is brought by the diluted tested plasma, and clotting is triggered with cephalin, activator and calcium (APTT). FVIII:C is the limiting factor and clotting time is inversely proportional to the concentration of FVIII:C.
FVIII:C Deficient Plasma (1 x 1 mL)
In US: For Research Use Only. Not for Use in Diagnostic Procedures. Deficient plasma for the assay of Factor VIII:C. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FVIII:C, which is brought by the diluted tested plasma, and clotting is triggered with cephalin, activator and calcium (APTT). FVIII:C is the limiting factor and clotting time is inversely proportional to the concentration of factor to measure.
FVIII:C Deficient Plasma (1 x 1 mL)
In US: For Research Use Only. Not for Use in Diagnostic Procedures. Deficient plasma for the assay of Factor VIII:C. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FVIII:C, which is brought by the diluted tested plasma, and clotting is triggered with cephalin, activator and calcium (APTT). FVIII:C is the limiting factor and clotting time is inversely proportional to the concentration of factor to measure.
FVIII:C Deficient Plasma (1 x 1 mL)
For In Vitro Diagnostic Use. In EU: This Product is CE Marked. Health Canada Licensed. Deficient plasma for the assay of Factor VIII:C. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FVIII:C, which is brought by the diluted tested plasma, and clotting is triggered with cephalin, activator and calcium (APTT). FVIII:C is the limiting factor and clotting time is inversely proportional to the concentration of factor to measure.
Factor VII Deficient Plasma (6 x 1 mL)
In US: For Research Use Only. Not for Use in Diagnostic Procedures. Deficient plasma for the assay of Factor VII. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FVII, which is brought by the diluted tested plasma, and clotting is triggered with calcium thromboplastin. FVII is the limiting factor and clotting time is inversely proportional to the concentration of FVII.
Factor VII Deficient Plasma (1 x 1 mL)
In US: For Research Use Only. Not for Use in Diagnostic Procedures. Deficient plasma for the assay of Factor VII. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FVII, which is brought by the diluted tested plasma, and clotting is triggered with calcium thromboplastin. FVII is the limiting factor and clotting time is inversely proportional to the concentration of FVII.
Factor V Deficient Plasma (6 x 1 mL)
In US: For Research Use Only. Not for Use in Diagnostic Procedures. Deficient plasma for the assay of Factor V. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FV, which is brought by the diluted tested plasma. Clotting is triggered with calcium thromboplastin. FV is the limiting factor and clotting time is inversely proportional to the concentration of FV.
Factor V Deficient Plasma (6 x 1 mL)
In US: For Research Use Only. Not for Use in Diagnostic Procedures. Deficient plasma for the assay of Factor V. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FV, which is brought by the diluted tested plasma. Clotting is triggered with calcium thromboplastin. FV is the limiting factor and clotting time is inversely proportional to the concentration of FV.
Factor V Deficient Plasma (1 x 1 mL)
In US: For Research Use Only. Not for Use in Diagnostic Procedures. Deficient plasma for the assay of Factor V. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FV, which is brought by the diluted tested plasma. Clotting is triggered with calcium thromboplastin. FV is the limiting factor and clotting time is inversely proportional to the concentration of FV.
Factor V Deficient Plasma (1 x 1 mL)
In US: For Research Use Only. Not for Use in Diagnostic Procedures. Deficient plasma for the assay of Factor V. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FV, which is brought by the diluted tested plasma. Clotting is triggered with calcium thromboplastin. FV is the limiting factor and clotting time is inversely proportional to the concentration of FV.
Prothrombin Deficient Plasma (6 x 1 mL)
In US: For Research Use Only. Not for Use in Diagnostic Procedures. Deficient plasma for the assay of Prothrombin. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FII, which is brought by the diluted tested plasma. Clotting is triggered with calcium thromboplastin. FII is the limiting factor and clotting time is inversely proportional to the concentration of FII.
Prothrombin Deficient Plasma (1 x 1 mL)
In US: For Research Use Only. Not for Use in Diagnostic Procedures. Deficient plasma for the assay of Prothrombin. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FII, which is brought by the diluted tested plasma. Clotting is triggered with calcium thromboplastin. FII is the limiting factor and clotting time is inversely proportional to the concentration of FII.
PT-Phenâ„¢ LRT (12 x 20 mL)
Clotting method for the in vitro quantitative determination of Prothrombin Time (PT), in human citrated plasma, using an automated method. This kit is for research use only and must not be used for patient diagnostis or treatment.
PT-Phenâ„¢ LRT (6 x 20 mL)
Clotting method for the in vitro quantitative determination of Prothrombin Time (PT), in human citrated plasma, using an automated method. This kit is for research use only and must not be used for patient diagnostis or treatment.
PT-Phenâ„¢ LRT (6 x 20 mL)
Clotting method for the in vitro quantitative determination of Prothrombin Time (PT), in human citrated plasma, using an automated method. This kit is for research use only and must not be used for patient diagnostis or treatment.
FIBRIPHENâ„¢ LRT
For Research Use Only. The FIBRIPHEN LRT kit is a clotting method for in vitro quantitative determination of Fibrinogen in human citrated plasma.
FIBRIPHENâ„¢ LRT
For Research Use Only. The FIBRIPHEN LRT kit is a clotting method for in vitro quantitative determination of Fibrinogen in human citrated plasma.
PT-Phenâ„¢ LRT (12 x 5 mL)
Clotting method for the in vitro quantitative determination of Prothrombin Time (PT), in human citrated plasma, using an automated method. This kit is for research use only and must not be used for patient diagnostis or treatment.
PT-Phenâ„¢ LRT (6 x 5 mL)
Clotting method for the in vitro quantitative determination of Prothrombin Time (PT), in human citrated plasma, using an automated method. This kit is for research use only and must not be used for patient diagnostis or treatment.
FIBRIPHENâ„¢ 5
In US and Canada: For Research Use Only. Not for Use in Diagnostic Procedures. Thrombin reagent for the quantitative determination of Fibrinogen in human citrated plasma using a clotting method (Clauss method).
FIBRIPHENâ„¢ 2
In US and Canada: For Research Use Only. Not for Use in Diagnostic Procedures. Thrombin reagent for the quantitative determination of Fibrinogen in human citrated plasma using a clotting method (Clauss method).
FIBRIPHENâ„¢ 2
In US and Canada: For Research Use Only. Not for Use in Diagnostic Procedures. Thrombin reagent for the quantitative determination of Fibrinogen in human citrated plasma using a clotting method (Clauss method).
FIBRIPHENâ„¢ 1
In US and Canada: For Research Use Only. Not for Use in Diagnostic Procedures. Thrombin reagent for the quantitative determination of Fibrinogen in human citrated plasma using a clotting method (Clauss method).
CEPHENâ„¢ 2.5 LS
In US and Canada: For Research Use Only. Not for Use in Diagnostic Procedures. For determination of activated partial Thromboplastin Time (aPTT) on citrated human plasma, using a manual, semi-automated clotting method with liquid reagents ready to use. This reagent offers a good sensitivity to the presence of Lupus Anticoagulant and can be used for an exploration of Lupus Anticoagulant.
CEPHENâ„¢ 1 LS
In US and Canada: For Research Use Only. Not for Use in Diagnostic Procedures. For determination of activated Partial Thromboplastin Time (aPTT) on citrated human plasma, using a manual, semi-automated or automated clotting method with liquid reagents ready to use. This reagent offers a good sensitivity to the presence of Lupus Anticoagulant and can be used for an exploration of Lupus Anticoagulant.
CEPHENâ„¢ 5 (12 x 5 mL)
In US and Canada: For Research Use Only. Not for Use in Diagnostic Procedures. For determination of activated Partial Thromboplastin Time (aPTT) on citrated human plasma, using a manual, semi-automated or automated clotting method with liquid reagents ready to use. This reagent has a low sensitivity to Lupus Anticoagulant and can be used for an exploration of Lupus Anticoagulant.
